Rosuvastatin dose-dependently improves flow-mediated dilation, but reduces adiponectin levels and insulin sensitivity in hypercholesterolaemic patients

Authors
Category Primary study
JournalEuroIntervention
Year 2016
This article has no abstract
Epistemonikos ID: 8762f35c41e532ef3814411942cf9ff10374729f
First added on: Feb 07, 2025